AzTrials
AzTrials

Cochlear ImplantNCT05360212

Anatomy-based Fitting in Cochear Implant Users

A study testing Anatomy-based fitting (ABF), Standard Fitting and Standard fitting+ ABF in people with Cochlear Implant and Outcomes, run by Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In this study, the performance with the CI is investigated over time in three groups of freshly implanted CI users. Both the standard frequency-band distribution and anatomy-based fitting will be used to compare outcomes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cochlear Implant, Outcomes, Quality of Life
What is being tested?
Anatomy-based fitting (ABF), Standard Fitting and Standard fitting+ ABF
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteSpain
Study dates
11 Mar 2022to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)
  • Post-OP CT scan of the CI electrode available
  • Subject implanted with MED-EL cochlear implant(s)
  • Subjects received a Flex28 or FlexSoft electrode
  • Subject planned to receive a SONNET 2 /RONDO3 audio processor on the newly implanted side
Show all 17Show fewer
  • Audio processor not yet activated on the newly implanted side
  • The most apical active electrode contact has to be inserted at least 450°
  • Minimum of 10 active channels can be activated
  • Fluent in Spanish
  • Signed and dated ICF before the start of any study-specific procedure
  • Specific inclusion criteria for the possible study groups • Bilateral CI users: Bilateral CI implantation SONNET 2/RONDO3 audio processor on the first ear implanted
  • 40% speech recognition a monosyllabic word Test in quiet at 65 dB SPL (last time tested) on the already implanted side
  • 40% speech recognition in a sentence test in noise (10 dB SNR) on the already implanted side First activation of the already implanted side between 3 and 12 months prior to study inclusion
  • Unilateral CI users: Unilateral CI implantation CI user with contralateral hearing ≥ 60 dB (PTA measured at 500, 1000, 2000, and 4000 Hz)
  • SSD CI users: Unilateral CI implantation CI user with contralateral hearing ≤30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥40 dB
  • Bimodal CI users: Unilateral CI implantation Contralateral ear adequately fitted with a hearing aid CI user with contralateral hearing ≥30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) CI user with contralateral hearing ≤55 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥15 dB

Who cannot join

  • Lack of compliance with any inclusion criteria
  • EAS user (user of an EAS audio processor)
  • Implanted with C40+, C40X and C40C
  • Implanted with an ABI or Split electrode array
  • Known allergic reactions to components of the investigational medical device
  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Luis Lassaletta, PhD contact

0034656898265

llasaletta@salud.madrid.org

Miryam Calvino, PhD contact

0034646354267

miryamcf@yahoo.com

Spain1 site, 1 recruiting
  • Hospital Universitario de La Paz

    Madrid, Madrid, 28046

    Miryam Calvino, miryamcf@yahoo.com

    Recruiting

Other trials in Spain

About this study

Official title: Anatomy-based Fitting in Unexperienced Cochlear Implant Users. Programación Basada en la anatomía en Usuarios Nuevos de Implante Coclear.

In this study, the performance with the CI is investigated over time in three groups of freshly implanted CI users. Both the standard frequency-band distribution and anatomy-based fitting will be used to compare outcomes.

Read the detailed description

In this study, the performance with the CI is investigated over time in three groups of freshly implanted CI users. The first group is fitted using the standard frequency-band distribution as implemented in MAESTRO 9. In the second group of users, an anatomy-based frequency distribution is used as per anatomy-based fitting in MAESTRO 9. The performance with anatomy-based fitting is assessed by comparing performance with the CI in these two groups over time.

The third group constitutes the within-subject design. These subjects are both fitting using the standard frequency-band distribution and the anatomy-based frequency distribution in MAESTRO 9. So, subjects will have both study maps on their audio processor throughout the whole study. They will have to change weekly between both fittings: standard fitting and anatomy-based fitting. Here, the performance with anatomy-based fitting is assessed by comparing performance with standard fitting and anatomy-based fitting.

Being tested
Anatomy-based fitting (ABF), Standard Fitting, Standard fitting+ ABF

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anatomy-based fitting (ABF)Procedure or surgery

    MAESTRO 9 can display the tonotopic frequency of each individual electrode channel imported from OTOPLAN to further support fitting based on these measures. The audiologist can set a frequency-band distribution that is more closely aligned to the tonotopic frequency distribution as imported from OTOPLAN.

  • Standard FittingProcedure or surgery

    These group is fitted using the standard frequency-band distribution as implemented in MAESTRO 9.

  • Standard fitting+ ABFProcedure or surgery

    Patients of this group are both fitting using the standard frequency-band distribution and the anatomy-based frequency distribution in MAESTRO 9. So, subjects will have both study maps on their audio processor throughout the whole study. They will have to change weekly between both fittings: standard fitting and anatomy-based fitting. Here, the performance with anatomy-based fitting is assessed by comparing performance with standard fitting and anatomy-based fitting.

Study groups in NCT05360212
Study groupRoleWhat they receive
Standard fittingPlacebo comparatorThe first group is fitted using the standard frequency-band distribution as implemented in MAESTRO 9
Receives: Procedure: Standard Fitting
Anatomy-based fittingExperimentalIn the second group of users, an anatomy-based frequency distribution is used as per anatomy-based fitting in MAESTRO 9
Receives: Procedure: Anatomy-based fitting (ABF)
Within-subject design: Standard fitting + ABFExperimentalThe third group constitutes the within-subject design. These subjects are both fitting using the standard frequency-band distribution and the anatomy-based frequency distribution in MAESTRO 9. So, subjects will have both study maps on their audio processor throughout the whole study. They will have to change weekly between both fittings: standard fitting and anatomy-based fitting.
Receives: Procedure: Standard fitting+ ABF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Result from the speech test in noise (S0N0)

    Speech perception evaluation with CI-only (MATRIX) with signal and noise in the same channel

    Measured: Month 6

  2. Results from speech tests in noise with spatially separated loudspeakers

    Speech perception evaluation with CI-only (MATRIX) with signal and noise in different channels

    Measured: Month 6

  3. Result from the speech test in quiet (S0)

    Speech perception evaluation with CI-only (disyllables)

    Measured: Month 6

Secondary outcomes (2)
  1. Results of quality of sound

    Subjective results through Hearing Implant Sound Quality Index 19. Scores range 19-133 points. Higher scores mean a better outcome.

    Measured: Month 6

  2. Results of quality of life in challenging situations

    Subjective results through Listening effort questionnaire. Scores range 21-93 points. Higher scores mean a better outcome.

    Measured: Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2022
  2. Study start11 Mar 2022
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05360212
Sponsor's protocol ID
PI-6128
Status last verified
Feb 2025
First submitted
23 Apr 2022
Last updated
12 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Anatomy-based fitting (ABF), Standard Fitting and Standard fitting+ ABF in people with Cochlear Implant and Outcomes, run by Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Luis Lassaletta, PhD (0034656898265, llasaletta@salud.madrid.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Result from the speech test in noise (S0N0) (time frame: Month 6). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in